Invesco Nasdaq Biotechnology ETF

Rentabilität für sechs Monate: -6.65%
Industrie: Health & Biotech Equities

Kategorie	Aktie, %	Menge
Healthcare	97.45295	195

Austausch	Aktie, %	Menge
NASDAQ	97.44	190
New York Stock Exchange	2.56	5

Teilen nach Land

Land	Menge	Unternehmen
United States	164	Gilead Sciences (aktie - 9.37%) Regeneron (aktie - 8.42%) Amgen (aktie - 7.88%) Vertex (aktie - 7.53%) Alnylam Pharmaceuticals, Inc. (aktie - 3.38%) Biogen (aktie - 2.84%) Moderna (aktie - 2.49%) Illumina (aktie - 2.07%) Summit Therapeutics Inc. (aktie - 1.58%) United Therapeutics Corporation (aktie - 1.51%) Incyte (aktie - 1.46%) Viatris (aktie - 1.37%) BioMarin Pharmaceutical (aktie - 1.31%) Vaxcyte, Inc. (aktie - 1.23%) Royalty Pharma plc (aktie - 1.22%) Neurocrine Biosciences (aktie - 1.17%) Insmed Incorporated (aktie - 1.17%) Sarepta Therapeutics, Inc. (aktie - 1.16%) Medpace Holdings, Inc. (aktie - 1.11%) Intra-Cellular Therapies, Inc. (aktie - 0.7887%) Exelixis (aktie - 0.7529%) Halozyme Therapeutics, Inc. (aktie - 0.7345%) Revolution Medicines, Inc. (aktie - 0.7339%) Cytokinetics, Incorporated (aktie - 0.6139%) Ionis Pharmaceuticals (aktie - 0.6014%) Nuvalent, Inc. (aktie - 0.588%) Blueprint Medicines Corporation (aktie - 0.549%) Krystal Biotech, Inc. (aktie - 0.5088%) Madrigal Pharmaceuticals, Inc. (aktie - 0.4971%) BridgeBio Pharma, Inc. (aktie - 0.4834%) Ultragenyx Pharmaceutical Inc. (aktie - 0.4712%) Arcellx, Inc. (aktie - 0.441%) ADMA Biologics, Inc. (aktie - 0.4408%) Axsome Therapeutics, Inc. (aktie - 0.431%) Apellis Pharmaceuticals, Inc. (aktie - 0.4297%) Denali Therapeutics Inc. (aktie - 0.4267%) Avidity Biosciences, Inc. (aktie - 0.421%) Immunovant, Inc. (aktie - 0.4167%) Crinetics Pharmaceuticals, Inc. (aktie - 0.4097%) Legend Biotech Corporation (aktie - 0.3996%) Dyne Therapeutics, Inc. (aktie - 0.3431%) Rhythm Pharmaceuticals, Inc. (aktie - 0.3198%) Amicus Therapeutics, Inc. (aktie - 0.3138%) Guardant Health, Inc. (aktie - 0.2993%) Kymera Therapeutics, Inc. (aktie - 0.2904%) Iovance Biotherapeutics, Inc. (aktie - 0.2789%) Geron Corporation (aktie - 0.2709%) Twist Bioscience Corporation (aktie - 0.2695%) PTC Therapeutics, Inc. (aktie - 0.267%) Edgewise Therapeutics, Inc. (aktie - 0.2653%) ACADIA Pharmaceuticals Inc. (aktie - 0.2613%) Protagonist Therapeutics, Inc. (aktie - 0.2596%) Veracyte, Inc. (aktie - 0.2595%) Agios Pharmaceuticals, Inc. (aktie - 0.2586%) IDEAYA Biosciences, Inc. (aktie - 0.2572%) SpringWorks Therapeutics, Inc. (aktie - 0.2527%) Arrowhead Pharmaceuticals, Inc. (aktie - 0.2527%) Janux Therapeutics, Inc. (aktie - 0.2493%) Myriad Genetics, Inc. (aktie - 0.2463%) Amphastar Pharmaceuticals, Inc. (aktie - 0.2365%) NantKwest, Inc. (aktie - 0.2319%) Vericel Corporation (aktie - 0.2254%) Vera Therapeutics, Inc. (aktie - 0.2213%) Intellia Therapeutics, Inc. (aktie - 0.2132%) Harmony Biosciences Holdings, Inc. (aktie - 0.2129%) Beam Therapeutics Inc. (aktie - 0.2068%) Keros Therapeutics, Inc. (aktie - 0.1999%) Rocket Pharmaceuticals, Inc. (aktie - 0.1871%) Akero Therapeutics, Inc. (aktie - 0.1863%) Ligand Pharmaceuticals Incorporated (aktie - 0.181%) Mirum Pharmaceuticals, Inc. (aktie - 0.1785%) MannKind Corporation (aktie - 0.1758%) Supernus Pharmaceuticals, Inc. (aktie - 0.1701%) Novavax, Inc. (aktie - 0.1693%) Arvinas, Inc. (aktie - 0.1686%) BioCryst Pharmaceuticals, Inc. (aktie - 0.162%) Harrow Health, Inc. (aktie - 0.1579%) Kura Oncology, Inc. (aktie - 0.1547%) Recursion Pharmaceuticals, Inc. (aktie - 0.154%) Syndax Pharmaceuticals, Inc. (aktie - 0.1525%) Dynavax Technologies Corporation (aktie - 0.145%) Nurix Therapeutics, Inc. (aktie - 0.1432%) ARS Pharmaceuticals, Inc. (aktie - 0.1387%) Ocular Therapeutix, Inc. (aktie - 0.135%) Ardelyx, Inc. (aktie - 0.135%) Xencor, Inc. (aktie - 0.1262%) Tarsus Pharmaceuticals, Inc. (aktie - 0.126%) Collegium Pharmaceutical, Inc. (aktie - 0.1229%) ANI Pharmaceuticals (aktie - 0.122%) Day One Biopharmaceuticals, Inc. (aktie - 0.1206%) Innoviva, Inc. (aktie - 0.1184%) Disc Medicine Opco Inc (aktie - 0.1159%) Maravai LifeSciences Holdings, Inc. (aktie - 0.1132%) Arcutis Biotherapeutics (aktie - 0.113%) Travere Therapeutics, Inc. (aktie - 0.1104%) Phathom Pharmaceuticals, Inc. (aktie - 0.1056%) Enliven Therapeutics, Inc. (aktie - 0.1045%) Vir Biotechnology, Inc. (aktie - 0.104%) Relay Therapeutics, Inc. (aktie - 0.1004%) Cullinan Oncology, Inc. (aktie - 0.0998%) Evolus, Inc. (aktie - 0.0992%) Sana Biotechnology, Inc. (aktie - 0.0986%) AnaptysBio, Inc. (aktie - 0.0983%) PetIQ, Inc. (aktie - 0.0875%) Castle Biosciences, Inc. (aktie - 0.0815%) 89bio, Inc. (aktie - 0.0785%) Erasca, Inc. (aktie - 0.0744%) Pliant Therapeutics, Inc. (aktie - 0.0732%) Olema Pharmaceuticals, Inc. (aktie - 0.0732%) ORIC Pharmaceuticals, Inc. (aktie - 0.0725%) Ironwood Pharmaceuticals, Inc. (aktie - 0.0691%) Adaptive Biotechnologies Corporation (aktie - 0.0679%) 4D Molecular Therapeutics, Inc. (aktie - 0.0671%) Replimune Group, Inc. (aktie - 0.0666%) Pacira BioSciences, Inc. (aktie - 0.0659%) Scholar Rock Holding Corporation (aktie - 0.0654%) Humacyte, Inc. (aktie - 0.0625%) Terns Pharmaceuticals, Inc. (aktie - 0.0625%) Savara Inc. (aktie - 0.0618%) REGENXBIO (aktie - 0.0594%) Y-mAbs Therapeutics, Inc. (aktie - 0.059%) Revance Therapeutics, Inc. (aktie - 0.0589%) Lexicon Pharmaceuticals, Inc. (aktie - 0.0589%) Allogene Therapeutics (aktie - 0.0586%) SIGA Technologies, Inc. (aktie - 0.0585%) Mineralys Therapeutics, Inc. (aktie - 0.058%) Alector, Inc. (aktie - 0.057%) Arcturus Therapeutics Holdings Inc. (aktie - 0.0543%) OmniAb, Inc. (aktie - 0.0536%) Pacific Biosciences of California, Inc. (aktie - 0.0536%) UroGen Pharma Ltd. (aktie - 0.0484%) Anavex Life Sciences Corp. (aktie - 0.047%) EyePoint Pharmaceuticals, Inc. (aktie - 0.0468%) Sage Therapeutics, Inc. (aktie - 0.0458%) Prime Medicine, Inc. (aktie - 0.0452%) KalVista Pharmaceuticals, Inc. (aktie - 0.0447%) Phibro Animal Health Corporation (aktie - 0.044%) MaxCyte, Inc. (aktie - 0.0438%) Verve Therapeutics, Inc. (aktie - 0.0435%) Xeris Pharmaceuticals, Inc. (aktie - 0.0423%) iTeos Therapeutics, Inc. (aktie - 0.0403%) Taysha Gene Therapies, Inc. (aktie - 0.0394%) Lyell Immunopharma, Inc. (aktie - 0.0383%) Voyager Therapeutics, Inc. (aktie - 0.0331%) Editas Medicine, Inc. (aktie - 0.031%) Biomea Fusion, Inc. (aktie - 0.0303%) Zentalis Pharmaceuticals, Inc. (aktie - 0.0299%) MeiraGTx Holdings plc (aktie - 0.027%) Vanda Pharmaceuticals (aktie - 0.0261%) Precigen, Inc. (aktie - 0.026%) Cabaletta Bio, Inc. (aktie - 0.0218%) Fulcrum Therapeutics, Inc. (aktie - 0.0207%) MacroGenics, Inc. (aktie - 0.0205%) Caribou Biosciences, Inc. (aktie - 0.018%) Ventyx Biosciences, Inc. (aktie - 0.0159%) Coherus BioSciences, Inc. (aktie - 0.0125%) ALX Oncology Holdings Inc. (aktie - 0.0109%) 23andMe Holding Co. (aktie - 0.0103%) Bluebird Bio (aktie - 0.009%) Marinus Pharmaceuticals, Inc. (aktie - 0.0085%) Aclaris Therapeutics, Inc. (aktie - 0.0083%) Ovid Therapeutics Inc. (aktie - 0.008%) RAPT Therapeutics, Inc. (aktie - 0.0065%) Reneo Pharmaceuticals, Inc. (aktie - 0.0049%)
United Kingdom	6	AstraZeneca PLC (aktie - 3.63%) Verona Pharma plc (aktie - 0.1978%) Immunocore Holdings plc (aktie - 0.123%) Centessa Pharmaceuticals Limited (aktie - 0.0886%) Bicycle Therapeutics plc (aktie - 0.0885%) Autolus Therapeutics plc (aktie - 0.074%)
Netherlands	3	argenx SE (aktie - 1.67%) Merus N.V. (aktie - 0.3246%) uniQure (aktie - 0.0266%)
France	1	Sanofi (aktie - 1.59%)
Germany	3	BioNTech SE (aktie - 1.07%) CureVac N.V. (aktie - 0.0711%) Atai Life Sciences N.V. (aktie - 0.0203%)
Denmark	2	Ascendis Pharma A/S (aktie - 0.8571%) Genmab A/S (aktie - 0.107%)
China	2	BeiGene, Ltd. (aktie - 0.8232%) Zai Lab Limited (aktie - 0.1044%)
Ireland	4	Jazz Pharmaceuticals plc (aktie - 0.6761%) Alkermes plc (aktie - 0.4621%) Prothena Corporation plc (aktie - 0.1124%) Amarin (aktie - 0.0231%)
Switzerland	2	CRISPR Therapeutics AG (aktie - 0.4046%) AC Immune SA (aktie - 0.0351%)
Canada	2	Xenon Pharmaceuticals Inc. (aktie - 0.2967%) AbCellera Biologics Inc. (aktie - 0.0776%)
Jersey	1	NovoCure Limited (aktie - 0.1852%)
Spain	1	Grifols, S.A. (aktie - 0.1067%)
Singapore	1	Wave Life Sciences Ltd. (aktie - 0.0701%)
Belgium	1	Galapagos NV (aktie - 0.0598%)
Hong Kong	1	Hutchison China MediTech Limited (aktie - 0.0501%)
Cayman Islands	1	Theravance Biopharma, Inc. (aktie - 0.0386%)

Bezahlen Sie Ihr Abonnement

Weitere Funktionen und Daten zur Unternehmens- und Portfolioanalyse sind im Abonnement verfügbar

Abonnieren

Aktie

Werkzeuge

Gemeinschaft

Kontakte

2025 © Investing Port
Kontakte | Werbung
Die Verwendung von porti.ru-Materialien ist nur zulässig, wenn ein aktiver indizierter Link zur Quelle vorhanden ist.